Stroke risk factors and outcomes among hospitalized women with atrial fibrillation

[1]  A. Camm,et al.  Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD‐AF , 2021, ESC heart failure.

[2]  J. Hartikainen,et al.  Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation: the FibStroke study , 2021, Annals of medicine.

[3]  D. Morrow,et al.  Biomarkers for Risk Assessment in Atrial Fibrillation. , 2020, Clinical chemistry.

[4]  Deepak L. Bhatt,et al.  Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease. , 2020, Circulation.

[5]  S. Goldhaber,et al.  Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy , 2020, Journal of Thrombosis and Thrombolysis.

[6]  W. Galanter,et al.  Impact of traditional risk factors for the outcomes of atrial fibrillation across race and ethnicity and sex groups , 2020, International journal of cardiology. Heart & vasculature.

[7]  M. Turakhia,et al.  Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation , 2020, Journal of the American Heart Association.

[8]  P. Nielsen,et al.  Female Sex as a Risk Modifier for Stroke Risk in Atrial Fibrillation: Using CHA2DS2-VASc versus CHA2DS2-VA for Stroke Risk Stratification in Atrial Fibrillation: A Note of Caution , 2020, Thrombosis and Haemostasis.

[9]  P. Battista,et al.  Sex Differences in Long-Term Mortality and Functional Outcome After Rehabilitation in Patients With Severe Stroke , 2020, Frontiers in Neurology.

[10]  M. Fine,et al.  Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data. , 2020, Journal of the National Medical Association.

[11]  M. Kavousi.  Differences in Epidemiology and Risk Factors for Atrial Fibrillation Between Women and Men , 2020, Frontiers in Cardiovascular Medicine.

[12]  I. V. Van Gelder,et al.  Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  F. Rosendaal,et al.  Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study , 2019, Research and practice in thrombosis and haemostasis.

[14]  A. Landman,et al.  Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT). , 2019, European heart journal.

[15]  L. Chen,et al.  Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation , 2019, bioRxiv.

[16]  C. Held,et al.  Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial , 2018, Circulation.

[17]  G. Lip,et al.  Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program. , 2018, The American journal of medicine.

[18]  G. Guyatt,et al.  Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial , 2018, The Lancet.

[19]  S. Goldhaber,et al.  Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation , 2018, TH Open.

[20]  Mircea Cinteza,et al.  A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial , 2017, The Lancet.

[21]  E. Soliman,et al.  Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction. , 2017, The American journal of cardiology.

[22]  B. Gersh,et al.  Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time , 2017, Journal of the American Heart Association.

[23]  A. Camm,et al.  Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry , 2017, BMJ Open.

[24]  S. Yusuf,et al.  Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation , 2016, Circulation.

[25]  T. Cai,et al.  Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis. , 2015, The Canadian journal of cardiology.

[26]  G. Lip,et al.  Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry , 2013, PloS one.

[27]  Paul Burton,et al.  Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[28]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[29]  Gregory Y H Lip,et al.  Improving stroke risk stratification in atrial fibrillation. , 2010, The American journal of medicine.

[30]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[31]  S. Schulman,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.

[32]  Maarten L. Simoons,et al.  The third universal definition of myocardial infarction , 2013 .